HBIO 8-K 2026-11-10

HARVARD BIOSCIENCE INC (HBIO) 8-K dated 2026-11-10 — accession 0001171843-26-007308.

HARVARD BIOSCIENCE INC (HBIO) is a medical instruments & supplies company listed on US.

HBIO: Harvard Bioscience Announces Third Quarter 2026 Financial Results

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported HBIO revenue for 2025-12-31 was $86.5M. Net income was -$56.7M. Revenue was down 8.1% from 2024-12-31 to 2025-12-31. HBIO currently screens at market cap $20.3M.

Not investment advice. The HBIO SEC hub lists recent forms. The stock page is the research view.